2 unknown. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 2 |
Follow Prevention: new trials by email Literature Review of Prevention trials Research Report on Prevention
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase II Study of SCT1000 in Healthy Women Aged 18 to 45 Years SCT1000, Gardasil®9, Gardasil® - Interventional, Prevention | Phase 2 | Unknown | Sinocelltech Ltd. | 1800 | 2021-10-19 | 2021-10-28 |
| Tenofovir/Levonorgestrel Intravaginal Ring and Tenofovir Intravaginal Ring TFV/LNG IVR, TFV IVR, Placebo IVR - HIV, Contraception | Phase 2 | Unknown | CONRAD | 50 | 2018-12-12 | 2020-01-14 |
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 (1) · Tenofovir (1)
CONRAD (1) · Sinocelltech Ltd. (1)
China (1) · Kenya (1)
Fengcai Zhu (1) · Nelly R. Mugo, MBChB (1)
PMID 16753240, PMID 21142263, PMID 35835755, PMID 36162740, PMID 37383290